Jim Cramer Predicts Trillion-Dollar Market Cap for Eli Lilly Amid Weight-Loss Drug Boom

BTCC / BTCC Square / Global Cryptocurrency /

Author:

Release Time:

2025-06-26 16:28:02

BTCCSquare news:

CNBC's Jim Cramer has doubled down on his bullish stance for Eli Lilly (LLY), forecasting the pharmaceutical giant could reach a trillion-dollar valuation. The 'Mad Money' host cites Zepbound, the company's blockbuster weight-loss drug, as the primary catalyst alongside a robust pipeline of cancer treatments and other therapies.

Eli Lilly's current $754 billion market cap leaves significant upside for investors betting on the obesity drug market's expansion. Cramer's endorsement reflects broader Wall Street optimism, with analysts viewing Lilly's development of a weight-loss pill as a potential industry gamechanger.

By:

Log in to Reply

Octora AI Unveils Real-Time Context Testing for AI Agents in Playground Update

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.